MNPR vs NRG · $431.4M cap vs P/E 145, rev $17.74B
Monopar Therapeutics Inc (MNPR) versus NRG Energy Inc. (NRG) — a side-by-side from cached financials, not a winner call.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
NRG Energy Inc. (NRG) is a utilities - independent power producers company listed on NYSE.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
Latest reported NRG revenue for 2026-06-30 was $17.74B. Net income was $631.0M. Revenue was up 72.9% from 2026-03-31 to 2026-06-30. NRG currently screens at market cap $27.88B and trailing P/E 145.2.
MNPR currently screens at market cap $431.4M. NRG currently screens at market cap $27.88B and trailing P/E 145.2.
Not investment advice. Open the MNPR and NRG stock pages for the full models.
Not investment advice.